Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing PHILADELPHIA, PENNSYLVANIA…
NORTHVALE, NJ / ACCESS Newswire / November 14, 2025 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer…
Continues Execution of Strategic Transformation and Advancement of Biologics Pipeline FREMONT, CA / ACCESS Newswire / November 14, 2025 /…
~ Third Quarter Highlighted by Initiation of Phase 3 Study of PF614, Underscoring Progress Toward Market Readiness and Commitment to…
SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 14, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company…
- Dermata announced a strategic pivot to develop and commercialize over-the-counter (OTC) skin care treatments -- Dermata plans to launch…
Conference Call Scheduled for Monday, November 17 at 11:30 AM ESTNorthvale, New Jersey--(Newsfile Corp. - November 14, 2025) - Elite…
Partnership integrates customized kitting, just-in-time operations, and nationwide distribution to accelerate decentralized and hybrid trials NEW BRUNSWICK, NEW JERSEY /…
BODYWELLE partners with local Miami businesses for a community-centered event focused on wellness, rejuvenation, and supporting Dalmatian Rescue, with yoga,…
Shareholders approve all EGM proposals related to the combination with NeuroXBusiness combination expected to close in December 2025Relief to be…